Literature DB >> 24462705

TLR3 regulates mycobacterial RNA-induced IL-10 production through the PI3K/AKT signaling pathway.

Wenjuan Bai1, Haipeng Liu2, Qun Ji3, Yilong Zhou4, Le Liang3, Ruijuan Zheng5, Jianxia Chen1, Zhonghua Liu6, Hong Yang7, Peng Zhang4, Stefan H E Kaufmann8, Baoxue Ge9.   

Abstract

Cytokine induction in response to Mycobacterium tuberculosis (Mtb) infection is critical for pathogen control, by (i) mediating innate immune effector functions and (ii) instructing specific adaptive immunity. IL-10 is an important anti-inflammatory cytokine involved in pathogenesis of tuberculosis (TB). Here, we show that TLR3, a sensor of extracellular viral or host RNA with stable stem structures derived from infected or damaged cells, is essential for Mtb-induced IL-10 production. Upon Mycobacterium bovis Bacillus Calmette-Guérin (BCG) infection, TLR3(-/-) macrophages expressed lower IL-10 but higher IL-12p40 production, accompanied by reduced phosphorylation of AKT at Ser473. BCG-infected TLR3(-/-) mice exhibited reduced IL-10 but elevated IL-12 expression compared to controls. Moreover, higher numbers of splenic Th1 cells and reduced pulmonary bacterial burden and tissue damage were observed in BCG-infected TLR3(-/-) mice. Finally, BCG RNA induced IL-10 in macrophages via TLR3-mediated activation of PI3K/AKT. Our findings demonstrate a critical role of TLR3-mediated regulation in the pathogenesis of mycobacterial infection involving mycobacterial RNA, which induces IL-10 through the PI3K/AKT signaling pathway.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Interleukin 10; Mycobacterium bovis BCG; Phosphoinositide 3-kinase (PI3K)/AKT; RNA; Toll-like receptor 3

Mesh:

Substances:

Year:  2014        PMID: 24462705     DOI: 10.1016/j.cellsig.2014.01.015

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  26 in total

1.  IL10 receptor is a novel therapeutic target in DLBCLs.

Authors:  W Béguelin; S Sawh; N Chambwe; F C Chan; Y Jiang; J-W Choo; D W Scott; A Chalmers; H Geng; L Tsikitas; W Tam; G Bhagat; R D Gascoyne; R Shaknovich
Journal:  Leukemia       Date:  2015-03-03       Impact factor: 11.528

2.  Toll-Like Receptor 3 (TLR3) Is Engaged in the Intracellular Survival of the Protozoan Parasite Leishmania (Leishmania) amazonensis.

Authors:  Carolina T Rath; Áislan C Vivarini; José Vitorino Dos Santos; Jorge M Medina; Alessandra M Saliba; Jeremy C Mottram; Ana Paula C A Lima; Teresa Cristina Calegari-Silva; Renata M Pereira; Ulisses G Lopes
Journal:  Infect Immun       Date:  2022-08-22       Impact factor: 3.609

Review 3.  Pathogenesis of SARS-CoV-2 and Mycobacterium tuberculosis Coinfection.

Authors:  Taif Shah; Zahir Shah; Nafeesa Yasmeen; Zulqarnain Baloch; Xueshan Xia
Journal:  Front Immunol       Date:  2022-06-16       Impact factor: 8.786

Review 4.  Innate immunity in tuberculosis: host defense vs pathogen evasion.

Authors:  Cui Hua Liu; Haiying Liu; Baoxue Ge
Journal:  Cell Mol Immunol       Date:  2017-09-11       Impact factor: 11.530

Review 5.  The microbiome at the pulmonary alveolar niche and its role in Mycobacterium tuberculosis infection.

Authors:  Alexander J Adami; Jorge L Cervantes
Journal:  Tuberculosis (Edinb)       Date:  2015-07-30       Impact factor: 3.131

6.  IRAK4 activity controls immune responses to intracellular bacteria Listeria monocytogenes and Mycobacterium smegmatis.

Authors:  Goutham Pattabiraman; Michael Murphy; Federica Agliano; Keaton Karlinsey; Andrei E Medvedev
Journal:  J Leukoc Biol       Date:  2018-05-11       Impact factor: 4.962

7.  Sensing of mycobacterial arabinogalactan by galectin-9 exacerbates mycobacterial infection.

Authors:  Xiangyang Wu; Yong Wu; Ruijuan Zheng; Fen Tang; Lianhua Qin; Detian Lai; Lu Zhang; Lingming Chen; Bo Yan; Hua Yang; Yang Wang; Feifei Li; Jinyu Zhang; Fei Wang; Lin Wang; Yajuan Cao; Mingtong Ma; Zhonghua Liu; Jianxia Chen; Xiaochen Huang; Jie Wang; Ruiliang Jin; Peng Wang; Qin Sun; Wei Sha; Liangdong Lyu; Pedro Moura-Alves; Anca Dorhoi; Gang Pei; Peng Zhang; Jiayu Chen; Shaorong Gao; Felix Randow; Gucheng Zeng; Chang Chen; Xin-Shan Ye; Stefan H E Kaufmann; Haipeng Liu; Baoxue Ge
Journal:  EMBO Rep       Date:  2021-05-13       Impact factor: 8.807

Review 8.  PI3K inhibitors in inflammation, autoimmunity and cancer.

Authors:  Anne-Katrien Stark; Srividya Sriskantharajah; Edith M Hessel; Klaus Okkenhaug
Journal:  Curr Opin Pharmacol       Date:  2015-06-18       Impact factor: 5.547

9.  Temporal Expression of Peripheral Blood Leukocyte Biomarkers in a Macaca fascicularis Infection Model of Tuberculosis; Comparison with Human Datasets and Analysis with Parametric/Non-parametric Tools for Improved Diagnostic Biomarker Identification.

Authors:  Sajid Javed; Leanne Marsay; Alice Wareham; Kuiama S Lewandowski; Ann Williams; Michael J Dennis; Sally Sharpe; Richard Vipond; Nigel Silman; Graham Ball; Karen E Kempsell
Journal:  PLoS One       Date:  2016-05-26       Impact factor: 3.240

Review 10.  Underwhelming or Misunderstood? Genetic Variability of Pattern Recognition Receptors in Immune Responses and Resistance to Mycobacterium tuberculosis.

Authors:  Jean-Yves Dubé; Vinicius M Fava; Erwin Schurr; Marcel A Behr
Journal:  Front Immunol       Date:  2021-06-30       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.